Skip to search formSkip to main contentSkip to account menu

DA 7218

Known as: DA-7218, DA7218 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tedizolid phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis.
OBJECTIVES Currently, for actinomycetoma, combined antimicrobial therapy is preferred to the use of a single compound. This is in… 
2009
2009
Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages.
BACKGROUND Nocardia are organisms that can escape the effects of both immune response and antimicrobial agents, due to their… 
2009
2009
Development of DA-7218, a Next-Generation Oxazolidinone
2007
2007
Pharmacokinetics of DA‐7218, a new oxazolidinone, and its active metabolite, DA‐7157, after intravenous and oral administration of DA‐7218 and DA‐7157 to rats
DA‐7218 (a prodrug of DA‐7157), a new oxazolidinone, was hydrolysed via phosphatase to form its active metabolite, DA‐7157, in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)